Literature DB >> 6975236

Further study on the humoral response of a highly-purified spleen-derived immunosuppressive peptide (SDIP).

N Duchange, L Millerioux, M Lenfant.   

Abstract

Some biological properties of a highly-purified non-cytotoxic spleen-derived immunosuppressive peptide (SDIP) have been investigated. SDIP was shown to inhibit the primary anti-sheep red blood cell (SRBC) response at the last step of differentiation of the lymphocyte. In the present study we demonstrated that this response seemed to be T- and adherent spleen-cell dependent as no inhibition was noticed either in the response to TNP-LPS, a T-independent antigen, or in the response to SRBC in adherent spleen cell-depleted cultures. SDIP activity did not occur through an inhibition of splenocytes DNA synthesis since [3H]-thymidine ([3H]-TdR) incorporation was not modified in mitogen or allogenic stimulated cultures. Conversely, SDIP could act through a stimulation of a T-cell subset as a low specific increase of [3H]-TdR was noticed in cultured thymocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975236      PMCID: PMC1555223     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

Authors:  T Tadakuma; C W Pierce
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.

Authors:  G N Douglas; A S Rubin
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

3.  An in vitro primary immune response to 2,4,6-trinitrophenyl substituted erythrocytes: response against carrier and hapten.

Authors:  J Kettman; R W Dutton
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

4.  Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes.

Authors:  Y Namba; B V Jegasothy; B H Waksman
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

5.  Effect of various thymic and nonthymic factors on in vitro antibody formation by spleen cells from nude mice.

Authors:  M J Blankwater; L A Levert; A C Swart; D W van Bekkum
Journal:  Cell Immunol       Date:  1978-02       Impact factor: 4.868

6.  Inhibition of the in vitro 19S and 7S antibody response by immunoglobulin-binding factor (IBF) from alloantigen-activated T cells.

Authors:  R H Gisler; W H Fridman
Journal:  Cell Immunol       Date:  1976-04       Impact factor: 4.868

7.  Function of 2-mercaptoethanol as a macrophage substitute in the primary immune response in vitro.

Authors:  H Lemke; H G Opitz
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

8.  Reversible binding of a T cell factor on IgG-coated sepharose beads.

Authors:  A Guimezanes; W H Fridman; R H Gisler; F M Kourilsky
Journal:  Eur J Immunol       Date:  1976-01       Impact factor: 5.532

9.  Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes.

Authors:  D Armerding; D H Katz
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

10.  Suppression of in vitro antibody synthesis by immunoglobulin-binding factor.

Authors:  R H Gisler; W H Fridman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  1 in total

1.  Characterization of a murine cytomegalovirus-induced immunosuppressive factor.

Authors:  P F Whyte; R Subramaniam; J B Hudson
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.